Fisher Wallace is a company best known for late-night infomercials on both television and YouTube channels for a product that treats depression, chronic pain, and insomnia with electricity. Specifically, the company uses transcranial alternating current stimulation (tACS) in the form of a proprietary waveform to alter the electrical signals in the brain. Unfortunately, despite numerous clinical trials, there has been no validation of any claims, and the company has instead leaned on a misleading marketing approach to try to convince consumers of the product's efficacy. In fact, Fisher Wallace has lobbied to ensure that the FDA did not move to reclassify surface bioelectronic devices as class III instead of class II, which would have required a premarket approval (PMA) process that would have required clinical proof of efficacy.
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)